Lyell Immunopharma (LYEL) Property, Plant & Equipment (Net) (2020 - 2026)
Powered by 
Analysis
Lyell Immunopharma (LYEL) Property, Plant & Equipment (Net) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.67 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 5.46 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 2.06 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 34.61 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.64 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 554.14 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 107.22 Mn |
| 10 | Lyell Immunopharma | 335.97 Mn | 335.97 Mn | - | 30.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.51 Mn |
| Mar 31, 2026 | 32.72 Mn |
| Dec 31, 2025 | 34.77 Mn |
| Sep 30, 2025 | 36.72 Mn |
| Jun 30, 2025 | 39.12 Mn |
| Mar 31, 2025 | 44.20 Mn |
| Dec 31, 2024 | 48.20 Mn |
| Sep 30, 2024 | 88.05 Mn |
| Jun 30, 2024 | 93.10 Mn |
| Mar 31, 2024 | 97.84 Mn |
| Dec 31, 2023 | 102.65 Mn |
| Sep 30, 2023 | 108.10 Mn |
| Jun 30, 2023 | 113.68 Mn |
| Mar 31, 2023 | 118.60 Mn |
| Dec 31, 2022 | 123.02 Mn |
| Sep 30, 2022 | 125.73 Mn |
| Jun 30, 2022 | 127.56 Mn |
| Mar 31, 2022 | 125.71 Mn |
| Dec 31, 2021 | 120.10 Mn |
| Sep 30, 2021 | 115.86 Mn |